North America Autism Spectrum Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), By Country and Growth Forecast, 2023

List of Tables

The North America Autism Spectrum Disorder Treatment Market would witness market growth of 5.1% CAGR during the forecast period (2023-2030).

The rising incidence of autism is expected to increase demand for medications used to treat people who exhibit symptoms of autism spectrum disorders and to enhance revenue generation. The essential seven conditions that are a part of ASD, according to the Autism Research Institute (ARI), are Fragile X Syndrome, Williams Syndrome, Landau-Kleffner Syndrome, Prader-Willi Syndrome, Angelman Syndrome, Tardive Dyskinesia, and Rett Syndrome. ASD-like symptoms like hand flapping, strange movements, and poor eye contact are present in 15% to 20% of people with fragile X syndrome. Thus, it is projected that an increasing number of autistic patients would fuel the market, along with late-stage pharmaceutical candidates like Zygel and STX209 (Arbaclofen).

Patients with ASD demonstrate a high degree of schedule dependence, a high level of sensitivity to changes in their surroundings, or a strong fixation. Early management improves symptom improvement over time, even if the illness is lifelong. Early detection guarantees early intervention during the critical developmental phase.

The prevalence of ASD, rising investment levels, and research & development spending are the main drivers of market expansion. The 2019 Canadian Health Survey on Children and Youth (CHSCY) found that 1 in 50 (or 2.0%) Canadian children and teens between the ages of 1 and 17 had an ASD diagnosis. Ages 5 to 11 had the highest prevalence of ASD (1 in 40 or 2.5%), followed by 12 to 17 years (1 in 53 or 1.9%) and ages 1 to 4 years (1 in 91 or 1.1%). The federal, state, and provincial governments in the United States and Canada have started a number of programs to help people with ASD, including financing for early intervention services, educational programs, and research. The market is expanding as a result of the market participants' rising number of initiatives. Such advancements are anticipated to encourage the creation of medications and consequently spur market expansion.

The US market dominated the North America Autism Spectrum Disorder Treatment Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $896.2 Million by 2030. The Canada market is poised to grow at a CAGR of 7.5% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 6.6% during (2023 - 2030).

Based on Type, the market is segmented into Stimulants, Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Sleep Medications, and Others. Based on Application, the market is segmented into Autistic Disorder, Asperger Syndrome, Pervasive, Developmental Disorder, and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Company, Merck & Co., Inc., Novartis AG, Eli Lilly and Company, Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Yamo Pharmaceuticals, and Curemark LLC

Scope of the Study

Market Segments covered in the Report:

By Type

Stimulants
Antipsychotic Drugs
Selective Serotonin Reuptake Inhibitors
Sleep Medications
Others

By Application

Autistic Disorder
Asperger Syndrome
Pervasive Developmental Disorder
Others

By Distribution Channel

Retail Pharmacy
Hospital Pharmacy
Online Pharmacy

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

F. Hoffmann-La Roche Ltd.
Bristol Myers Squibb Company
Merck & Co., Inc.
Novartis AG
Eli Lilly And Company
Pfizer Inc.
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd.
Yamo Pharmaceuticals
Curemark LLC

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Autism Spectrum Disorder Treatment Market, by Type
- 1.4.2 North America Autism Spectrum Disorder Treatment Market, by Application
- 1.4.3 North America Autism Spectrum Disorder Treatment Market, by Distribution Channel
- 1.4.4 North America Autism Spectrum Disorder Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. North America Autism Spectrum Disorder Treatment Market, by Type

4.1 North America Stimulants Market, by Country
4.2 North America Antipsychotic Drugs Market, by Country
4.3 North America Selective Serotonin Reuptake Inhibitors Market, by Country
4.4 North America Sleep Medications Market, by Country
4.5 North America Others Market, by Country

Chapter 5. North America Autism Spectrum Disorder Treatment Market, by Application

5.1 North America Autistic Disorder Market, by Country
5.2 North America Asperger Syndrome Market, by Country
5.3 North America Pervasive Developmental Disorder Market, by Country
5.4 North America Others Market, by Country

Chapter 6. North America Autism Spectrum Disorder Treatment Market, by Distribution Channel

6.1 North America Retail Pharmacy Market, by Country
6.2 North America Hospital Pharmacy Market, by Country
6.3 North America Online Pharmacy Market, by Country

Chapter 7. North America Autism Spectrum Disorder Treatment Market, by Country

7.1 US Autism Spectrum Disorder Treatment Market
- 7.1.1 US Autism Spectrum Disorder Treatment Market, by Type
- 7.1.2 US Autism Spectrum Disorder Treatment Market, by Application
- 7.1.3 US Autism Spectrum Disorder Treatment Market, by Distribution Channel
7.2 Canada Autism Spectrum Disorder Treatment Market
- 7.2.1 Canada Autism Spectrum Disorder Treatment Market, by Type
- 7.2.2 Canada Autism Spectrum Disorder Treatment Market, by Application
- 7.2.3 Canada Autism Spectrum Disorder Treatment Market, by Distribution Channel
7.3 Mexico Autism Spectrum Disorder Treatment Market
- 7.3.1 Mexico Autism Spectrum Disorder Treatment Market, by Type
- 7.3.2 Mexico Autism Spectrum Disorder Treatment Market, by Application
- 7.3.3 Mexico Autism Spectrum Disorder Treatment Market, by Distribution Channel
7.4 Rest of North America Autism Spectrum Disorder Treatment Market
- 7.4.1 Rest of North America Autism Spectrum Disorder Treatment Market, by Type
- 7.4.2 Rest of North America Autism Spectrum Disorder Treatment Market, by Application
- 7.4.3 Rest of North America Autism Spectrum Disorder Treatment Market, by Distribution Channel

Chapter 8. Company Profiles

8.1 F. Hoffmann-La Roche Ltd.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Bristol Myers Squibb Company
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 SWOT Analysis
8.3 Merck & Co., Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
8.4 Novartis AG
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 SWOT Analysis
8.5 Eli Lilly And Company
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
8.6 Pfizer, Inc.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional & Segmental Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 SWOT Analysis
8.7 Johnson & Johnson
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental & Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
8.8 Otsuka Pharmaceutical Co., Ltd.
- 8.8.1 Company Overview
- 8.8.2 SWOT Analysis
8.9 Yamo Pharmaceuticals
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
8.10. Curemark, LLC
- 8.10.1 Company Overview
- 8.10.2 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 2 North America Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 3 North America Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
TABLE 4 North America Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
TABLE 5 North America Stimulants Market, by Country, 2019 - 2022, USD Million
TABLE 6 North America Stimulants Market, by Country, 2023 - 2030, USD Million
TABLE 7 North America Antipsychotic Drugs Market, by Country, 2019 - 2022, USD Million
TABLE 8 North America Antipsychotic Drugs Market, by Country, 2023 - 2030, USD Million
TABLE 9 North America Selective Serotonin Reuptake Inhibitors Market, by Country, 2019 - 2022, USD Million
TABLE 10 North America Selective Serotonin Reuptake Inhibitors Market, by Country, 2023 - 2030, USD Million
TABLE 11 North America Sleep Medications Market, by Country, 2019 - 2022, USD Million
TABLE 12 North America Sleep Medications Market, by Country, 2023 - 2030, USD Million
TABLE 13 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 North America Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
TABLE 16 North America Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
TABLE 17 North America Autistic Disorder Market, by Country, 2019 - 2022, USD Million
TABLE 18 North America Autistic Disorder Market, by Country, 2023 - 2030, USD Million
TABLE 19 North America Asperger Syndrome Market, by Country, 2019 - 2022, USD Million
TABLE 20 North America Asperger Syndrome Market, by Country, 2023 - 2030, USD Million
TABLE 21 North America Pervasive Developmental Disorder Market, by Country, 2019 - 2022, USD Million
TABLE 22 North America Pervasive Developmental Disorder Market, by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 26 North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 27 North America Retail Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 28 North America Retail Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 29 North America Hospital Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 30 North America Hospital Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 31 North America Online Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 32 North America Online Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 33 North America Autism Spectrum Disorder Treatment Market, by Country, 2019 - 2022, USD Million
TABLE 34 North America Autism Spectrum Disorder Treatment Market, by Country, 2023 - 2030, USD Million
TABLE 35 US Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 36 US Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 37 US Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
TABLE 38 US Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
TABLE 39 US Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
TABLE 40 US Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
TABLE 41 US Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 US Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 Canada Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 44 Canada Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 45 Canada Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
TABLE 46 Canada Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
TABLE 47 Canada Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
TABLE 48 Canada Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
TABLE 49 Canada Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Canada Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Mexico Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 52 Mexico Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 53 Mexico Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
TABLE 54 Mexico Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
TABLE 55 Mexico Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
TABLE 56 Mexico Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
TABLE 57 Mexico Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Mexico Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Rest of North America Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 60 Rest of North America Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 61 Rest of North America Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
TABLE 62 Rest of North America Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
TABLE 63 Rest of North America Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
TABLE 64 Rest of North America Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
TABLE 65 Rest of North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Rest of North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 68 Key Information - Bristol Myers Squibb Company
TABLE 69 Key Information - Merck & Co., Inc.
TABLE 70 Key Information - Novartis AG
TABLE 71 Key Information - Eli Lilly And Company
TABLE 72 Key Information - Pfizer, Inc.
TABLE 73 Key Information - Johnson & Johnson
TABLE 74 key information - Otsuka Pharmaceutical Co., Ltd.
TABLE 75 Key Information - Yamo Pharmaceuticals
TABLE 76 Key Information - Curemark, LLC

North America Autism Spectrum Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents